Home

Vijay K Lathi

CIK 1340806 · last filed 2018-05-31

Vijay K Lathi is a corporate insider who has filed 17 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ITRM, was dated May 31, 2018. Across all open-market trades the lifetime net is −$216.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.34M

Companies

6

Total Filings

17

Lifetime Open-Market Net

-$216.69M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Iterum Therapeutics plc (ITRM) Delisted 10%+ Owner 384,615 $0.03 $11.5K $17.23M 1 2018-05-31
IRTC Director 85,785 $108.84 $9.34M -$80.59M 10 2018-03-12
Durata Therapeutics, Inc. (DRTX) Delisted 10%+ Owner 0 — — $0 1 2014-11-18
Aravive, Inc. (VSAR) Delisted 10%+ Owner 2,559,374 — — -$126.23M 2 2014-11-13
Lite Strategy, Inc. (MEIP) Delisted 10%+ Owner 1,680,475 $3.20 $5.38M -$27.10M 1 2013-11-25
SGX PHARMACEUTICALS, INC. (SGXP) Delisted Director — — — $0 1 2007-05-17

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-05-31 Iterum Therapeutics plc (ITRM) Delisted Mixed +2,912,606 $17.23M EDGAR
2018-03-12 IRTC Sell (S) −114,018 -$7.58M EDGAR
2018-02-26 IRTC Sell (S) −45,723 -$3.00M EDGAR
2018-02-22 IRTC Sell (S) −169,000 -$10.55M EDGAR
2017-12-07 IRTC Sell (S) −150,000 -$7.88M EDGAR
2017-11-20 IRTC Sell (S) −225,000 -$11.72M EDGAR
2017-09-15 IRTC Mixed +37,776 -$1.71M EDGAR
2017-07-07 IRTC Grant (A) +1,405 $0 EDGAR
2017-06-08 IRTC Sell (S) −430,624 -$16.19M EDGAR
2017-05-16 IRTC Sell (S) −645,000 -$22.38M EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.